English
简体中文
Total: £ 56.28
Published Date: 2025-03-24 | Pages: 82 | Tables: 87 | Pharma & Healthcare
The global market for Pharma-Grade Hyaluronic Acid was valued at US$ 202 million in the year 2024 and is projected to reach a revised size of US$ 398 million by 2031, growing at a CAGR of 10.3% during the forecast period.
Hyaluronic acid is a naturally occurring substance that helps retain moisture in the skin and eyes and lubricates the joints. Pharma-Grade Hyaluronic Acid is generally used in pharmaceutical formulations, such as Injection Product and Eye Drops for osteoarthritis of the knee joint.
Hyaluronic acid also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique among glycosaminoglycans in that it is nonsulfated, forms in the plasma membrane instead of the Golgi apparatus, and can be very large: human synovial HA averages about 7 million Da per molecule, or about 20000 disaccharide monomers, while other sources mention 3–4 million Da. As one of the chief components of the extracellular matrix, hyaluronan contributes significantly to cell proliferation and migration, and may also be involved in the progression of some malignant tumors. In this report, we only study the Pharma-Grade Hyaluronic Acid.
The rising preference rates and applications of hyaluronic acid products in dry eye and osteoarthritis management fuels the growth rate of the market significantly. the growing prevalence of osteoarthritis has fueled demand for hyaluronic acid-based treatments, as it is used in viscosupplementation injections to relieve joint pain. Rising consumer awareness of health, along with advancements in biotechnology, has further expanded the market's growth.
However, adverse effects associated with treatment or therapy such as redness and itching, as well as high production costs and regulatory hurdles. The process of extracting and purifying hyaluronic acid, particularly from natural sources, can be expensive, leading to higher product prices. Additionally, the stringent regulatory requirements for pharmaceutical-grade products create barriers for manufacturers, as they must meet rigorous standards for safety and efficacy. These factors can limit the entry of new players into the market and slow down overall growth.
Global key players of pharma-grade hyaluronic acid include Bloomage Biotech, HTL Biotechnology, Kewpie, Contipro, Fidia Farmaceutici, etc. The top five players hold a share about 78%. Europe is the largest market, has a share about 51%, followed by North America and Asia-Pacific , with share 26% and 21%, separately.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharma-Grade Hyaluronic Acid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma-Grade Hyaluronic Acid.
The Pharma-Grade Hyaluronic Acid market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharma-Grade Hyaluronic Acid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma-Grade Hyaluronic Acid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bloomage Biotech
AWA Biopharm
Kewpie
Contipro
Seikagaku
HTL Biotechnology
Fidia Farmaceutici
Segment by Type
Microbial Fermentation
Animal Tissue
Segment by Application
Injection Product
Eye Drops
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharma-Grade Hyaluronic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharma-Grade Hyaluronic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Pharma-Grade Hyaluronic Acid Market Overview
1.1 Product Definition
1.2 Pharma-Grade Hyaluronic Acid by Type
1.2.1 Global Pharma-Grade Hyaluronic Acid Market Value Comparison by Type (2024 VS 2031)
1.2.2 Microbial Fermentation
1.2.3 Animal Tissue
1.3 Pharma-Grade Hyaluronic Acid by Application
1.3.1 Global Pharma-Grade Hyaluronic Acid Market Value by Application (2024 VS 2031)
1.3.2 Injection Product
1.3.3 Eye Drops
1.4 Global Pharma-Grade Hyaluronic Acid Market Size Estimates and Forecasts
1.4.1 Global Pharma-Grade Hyaluronic Acid Revenue 2020-2031
1.4.2 Global Pharma-Grade Hyaluronic Acid Sales 2020-2031
1.4.3 Global Pharma-Grade Hyaluronic Acid Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pharma-Grade Hyaluronic Acid Market Competition by Manufacturers
2.1 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pharma-Grade Hyaluronic Acid Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pharma-Grade Hyaluronic Acid, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharma-Grade Hyaluronic Acid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharma-Grade Hyaluronic Acid, Product Type & Application
2.7 Global Key Manufacturers of Pharma-Grade Hyaluronic Acid, Date of Enter into This Industry
2.8 Global Pharma-Grade Hyaluronic Acid Market Competitive Situation and Trends
2.8.1 Global Pharma-Grade Hyaluronic Acid Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pharma-Grade Hyaluronic Acid Players Market Share by Revenue
2.8.3 Global Pharma-Grade Hyaluronic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharma-Grade Hyaluronic Acid Market Scenario by Region
3.1 Global Pharma-Grade Hyaluronic Acid Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pharma-Grade Hyaluronic Acid Sales by Region: 2020-2031
3.2.1 Global Pharma-Grade Hyaluronic Acid Sales by Region: 2020-2025
3.2.2 Global Pharma-Grade Hyaluronic Acid Sales by Region: 2026-2031
3.3 Global Pharma-Grade Hyaluronic Acid Revenue by Region: 2020-2031
3.3.1 Global Pharma-Grade Hyaluronic Acid Revenue by Region: 2020-2025
3.3.2 Global Pharma-Grade Hyaluronic Acid Revenue by Region: 2026-2031
3.4 North America Pharma-Grade Hyaluronic Acid Market Facts & Figures by Country
3.4.1 North America Pharma-Grade Hyaluronic Acid Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pharma-Grade Hyaluronic Acid Sales by Country (2020-2031)
3.4.3 North America Pharma-Grade Hyaluronic Acid Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharma-Grade Hyaluronic Acid Market Facts & Figures by Country
3.5.1 Europe Pharma-Grade Hyaluronic Acid Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pharma-Grade Hyaluronic Acid Sales by Country (2020-2031)
3.5.3 Europe Pharma-Grade Hyaluronic Acid Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharma-Grade Hyaluronic Acid Market Facts & Figures by Region
3.6.1 Asia Pacific Pharma-Grade Hyaluronic Acid Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pharma-Grade Hyaluronic Acid Sales by Region (2020-2031)
3.6.3 Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pharma-Grade Hyaluronic Acid Market Facts & Figures by Country
3.7.1 Latin America Pharma-Grade Hyaluronic Acid Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pharma-Grade Hyaluronic Acid Sales by Country (2020-2031)
3.7.3 Latin America Pharma-Grade Hyaluronic Acid Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharma-Grade Hyaluronic Acid Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharma-Grade Hyaluronic Acid Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pharma-Grade Hyaluronic Acid Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharma-Grade Hyaluronic Acid Sales by Type (2020-2031)
4.1.1 Global Pharma-Grade Hyaluronic Acid Sales by Type (2020-2025)
4.1.2 Global Pharma-Grade Hyaluronic Acid Sales by Type (2026-2031)
4.1.3 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Type (2020-2031)
4.2 Global Pharma-Grade Hyaluronic Acid Revenue by Type (2020-2031)
4.2.1 Global Pharma-Grade Hyaluronic Acid Revenue by Type (2020-2025)
4.2.2 Global Pharma-Grade Hyaluronic Acid Revenue by Type (2026-2031)
4.2.3 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Type (2020-2031)
4.3 Global Pharma-Grade Hyaluronic Acid Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pharma-Grade Hyaluronic Acid Sales by Application (2020-2031)
5.1.1 Global Pharma-Grade Hyaluronic Acid Sales by Application (2020-2025)
5.1.2 Global Pharma-Grade Hyaluronic Acid Sales by Application (2026-2031)
5.1.3 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Application (2020-2031)
5.2 Global Pharma-Grade Hyaluronic Acid Revenue by Application (2020-2031)
5.2.1 Global Pharma-Grade Hyaluronic Acid Revenue by Application (2020-2025)
5.2.2 Global Pharma-Grade Hyaluronic Acid Revenue by Application (2026-2031)
5.2.3 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Application (2020-2031)
5.3 Global Pharma-Grade Hyaluronic Acid Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bloomage Biotech
6.1.1 Bloomage Biotech Company Information
6.1.2 Bloomage Biotech Description and Business Overview
6.1.3 Bloomage Biotech Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bloomage Biotech Pharma-Grade Hyaluronic Acid Product Portfolio
6.1.5 Bloomage Biotech Recent Developments/Updates
6.2 AWA Biopharm
6.2.1 AWA Biopharm Company Information
6.2.2 AWA Biopharm Description and Business Overview
6.2.3 AWA Biopharm Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AWA Biopharm Pharma-Grade Hyaluronic Acid Product Portfolio
6.2.5 AWA Biopharm Recent Developments/Updates
6.3 Kewpie
6.3.1 Kewpie Company Information
6.3.2 Kewpie Description and Business Overview
6.3.3 Kewpie Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Kewpie Pharma-Grade Hyaluronic Acid Product Portfolio
6.3.5 Kewpie Recent Developments/Updates
6.4 Contipro
6.4.1 Contipro Company Information
6.4.2 Contipro Description and Business Overview
6.4.3 Contipro Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Contipro Pharma-Grade Hyaluronic Acid Product Portfolio
6.4.5 Contipro Recent Developments/Updates
6.5 Seikagaku
6.5.1 Seikagaku Company Information
6.5.2 Seikagaku Description and Business Overview
6.5.3 Seikagaku Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Seikagaku Pharma-Grade Hyaluronic Acid Product Portfolio
6.5.5 Seikagaku Recent Developments/Updates
6.6 HTL Biotechnology
6.6.1 HTL Biotechnology Company Information
6.6.2 HTL Biotechnology Description and Business Overview
6.6.3 HTL Biotechnology Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2020-2025)
6.6.4 HTL Biotechnology Pharma-Grade Hyaluronic Acid Product Portfolio
6.6.5 HTL Biotechnology Recent Developments/Updates
6.7 Fidia Farmaceutici
6.7.1 Fidia Farmaceutici Company Information
6.7.2 Fidia Farmaceutici Description and Business Overview
6.7.3 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Product Portfolio
6.7.5 Fidia Farmaceutici Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharma-Grade Hyaluronic Acid Industry Chain Analysis
7.2 Pharma-Grade Hyaluronic Acid Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharma-Grade Hyaluronic Acid Production Mode & Process Analysis
7.4 Pharma-Grade Hyaluronic Acid Sales and Marketing
7.4.1 Pharma-Grade Hyaluronic Acid Sales Channels
7.4.2 Pharma-Grade Hyaluronic Acid Distributors
7.5 Pharma-Grade Hyaluronic Acid Customer Analysis
8 Pharma-Grade Hyaluronic Acid Market Dynamics
8.1 Pharma-Grade Hyaluronic Acid Industry Trends
8.2 Pharma-Grade Hyaluronic Acid Market Drivers
8.3 Pharma-Grade Hyaluronic Acid Market Challenges
8.4 Pharma-Grade Hyaluronic Acid Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pharma-Grade Hyaluronic Acid Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pharma-Grade Hyaluronic Acid Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Pharma-Grade Hyaluronic Acid Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pharma-Grade Hyaluronic Acid Sales (Kg) of Key Manufacturers (2020-2025)
Table 5. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Pharma-Grade Hyaluronic Acid Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Pharma-Grade Hyaluronic Acid Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Pharma-Grade Hyaluronic Acid Average Price (US$/Kg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Pharma-Grade Hyaluronic Acid, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pharma-Grade Hyaluronic Acid, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pharma-Grade Hyaluronic Acid, Product Type & Application
Table 12. Global Key Manufacturers of Pharma-Grade Hyaluronic Acid, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharma-Grade Hyaluronic Acid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma-Grade Hyaluronic Acid as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharma-Grade Hyaluronic Acid Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Pharma-Grade Hyaluronic Acid Sales by Region (2020-2025) & (Kg)
Table 18. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Region (2020-2025)
Table 19. Global Pharma-Grade Hyaluronic Acid Sales by Region (2026-2031) & (Kg)
Table 20. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Region (2026-2031)
Table 21. Global Pharma-Grade Hyaluronic Acid Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Region (2020-2025)
Table 23. Global Pharma-Grade Hyaluronic Acid Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Region (2026-2031)
Table 25. North America Pharma-Grade Hyaluronic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Pharma-Grade Hyaluronic Acid Sales by Country (2020-2025) & (Kg)
Table 27. North America Pharma-Grade Hyaluronic Acid Sales by Country (2026-2031) & (Kg)
Table 28. North America Pharma-Grade Hyaluronic Acid Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Pharma-Grade Hyaluronic Acid Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Pharma-Grade Hyaluronic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Pharma-Grade Hyaluronic Acid Sales by Country (2020-2025) & (Kg)
Table 32. Europe Pharma-Grade Hyaluronic Acid Sales by Country (2026-2031) & (Kg)
Table 33. Europe Pharma-Grade Hyaluronic Acid Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Pharma-Grade Hyaluronic Acid Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Pharma-Grade Hyaluronic Acid Sales by Region (2020-2025) & (Kg)
Table 37. Asia Pacific Pharma-Grade Hyaluronic Acid Sales by Region (2026-2031) & (Kg)
Table 38. Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pharma-Grade Hyaluronic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Pharma-Grade Hyaluronic Acid Sales by Country (2020-2025) & (Kg)
Table 42. Latin America Pharma-Grade Hyaluronic Acid Sales by Country (2026-2031) & (Kg)
Table 43. Latin America Pharma-Grade Hyaluronic Acid Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pharma-Grade Hyaluronic Acid Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Pharma-Grade Hyaluronic Acid Sales by Country (2020-2025) & (Kg)
Table 47. Middle East and Africa Pharma-Grade Hyaluronic Acid Sales by Country (2026-2031) & (Kg)
Table 48. Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Pharma-Grade Hyaluronic Acid Sales (Kg) by Type (2020-2025)
Table 51. Global Pharma-Grade Hyaluronic Acid Sales (Kg) by Type (2026-2031)
Table 52. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Type (2020-2025)
Table 53. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Type (2026-2031)
Table 54. Global Pharma-Grade Hyaluronic Acid Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Pharma-Grade Hyaluronic Acid Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Type (2020-2025)
Table 57. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Type (2026-2031)
Table 58. Global Pharma-Grade Hyaluronic Acid Price (US$/Kg) by Type (2020-2025)
Table 59. Global Pharma-Grade Hyaluronic Acid Price (US$/Kg) by Type (2026-2031)
Table 60. Global Pharma-Grade Hyaluronic Acid Sales (Kg) by Application (2020-2025)
Table 61. Global Pharma-Grade Hyaluronic Acid Sales (Kg) by Application (2026-2031)
Table 62. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Application (2020-2025)
Table 63. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Application (2026-2031)
Table 64. Global Pharma-Grade Hyaluronic Acid Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Pharma-Grade Hyaluronic Acid Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Application (2020-2025)
Table 67. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Application (2026-2031)
Table 68. Global Pharma-Grade Hyaluronic Acid Price (US$/Kg) by Application (2020-2025)
Table 69. Global Pharma-Grade Hyaluronic Acid Price (US$/Kg) by Application (2026-2031)
Table 70. Bloomage Biotech Company Information
Table 71. Bloomage Biotech Description and Business Overview
Table 72. Bloomage Biotech Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 73. Bloomage Biotech Pharma-Grade Hyaluronic Acid Product
Table 74. Bloomage Biotech Recent Developments/Updates
Table 75. AWA Biopharm Company Information
Table 76. AWA Biopharm Description and Business Overview
Table 77. AWA Biopharm Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 78. AWA Biopharm Pharma-Grade Hyaluronic Acid Product
Table 79. AWA Biopharm Recent Developments/Updates
Table 80. Kewpie Company Information
Table 81. Kewpie Description and Business Overview
Table 82. Kewpie Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 83. Kewpie Pharma-Grade Hyaluronic Acid Product
Table 84. Kewpie Recent Developments/Updates
Table 85. Contipro Company Information
Table 86. Contipro Description and Business Overview
Table 87. Contipro Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 88. Contipro Pharma-Grade Hyaluronic Acid Product
Table 89. Contipro Recent Developments/Updates
Table 90. Seikagaku Company Information
Table 91. Seikagaku Description and Business Overview
Table 92. Seikagaku Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 93. Seikagaku Pharma-Grade Hyaluronic Acid Product
Table 94. Seikagaku Recent Developments/Updates
Table 95. HTL Biotechnology Company Information
Table 96. HTL Biotechnology Description and Business Overview
Table 97. HTL Biotechnology Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 98. HTL Biotechnology Pharma-Grade Hyaluronic Acid Product
Table 99. HTL Biotechnology Recent Developments/Updates
Table 100. Fidia Farmaceutici Company Information
Table 101. Fidia Farmaceutici Description and Business Overview
Table 102. Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 103. Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Product
Table 104. Fidia Farmaceutici Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Pharma-Grade Hyaluronic Acid Distributors List
Table 108. Pharma-Grade Hyaluronic Acid Customers List
Table 109. Pharma-Grade Hyaluronic Acid Market Trends
Table 110. Pharma-Grade Hyaluronic Acid Market Drivers
Table 111. Pharma-Grade Hyaluronic Acid Market Challenges
Table 112. Pharma-Grade Hyaluronic Acid Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharma-Grade Hyaluronic Acid
Figure 2. Global Pharma-Grade Hyaluronic Acid Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharma-Grade Hyaluronic Acid Market Share by Type: 2024 & 2031
Figure 4. Microbial Fermentation Product Picture
Figure 5. Animal Tissue Product Picture
Figure 6. Global Pharma-Grade Hyaluronic Acid Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Pharma-Grade Hyaluronic Acid Market Share by Application: 2024 & 2031
Figure 8. Injection Product
Figure 9. Eye Drops
Figure 10. Global Pharma-Grade Hyaluronic Acid Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Pharma-Grade Hyaluronic Acid Market Size (2020-2031) & (US$ Million)
Figure 12. Global Pharma-Grade Hyaluronic Acid Sales (2020-2031) & (Kg)
Figure 13. Global Pharma-Grade Hyaluronic Acid Average Price (US$/Kg) & (2020-2031)
Figure 14. Pharma-Grade Hyaluronic Acid Report Years Considered
Figure 15. Pharma-Grade Hyaluronic Acid Sales Share by Manufacturers in 2024
Figure 16. Global Pharma-Grade Hyaluronic Acid Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Pharma-Grade Hyaluronic Acid Players: Market Share by Revenue in Pharma-Grade Hyaluronic Acid in 2024
Figure 18. Pharma-Grade Hyaluronic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Pharma-Grade Hyaluronic Acid Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Pharma-Grade Hyaluronic Acid Sales Market Share by Country (2020-2031)
Figure 21. North America Pharma-Grade Hyaluronic Acid Revenue Market Share by Country (2020-2031)
Figure 22. United States Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Pharma-Grade Hyaluronic Acid Sales Market Share by Country (2020-2031)
Figure 25. Europe Pharma-Grade Hyaluronic Acid Revenue Market Share by Country (2020-2031)
Figure 26. Germany Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Pharma-Grade Hyaluronic Acid Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Pharma-Grade Hyaluronic Acid Revenue Market Share by Region (2020-2031)
Figure 33. China Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Pharma-Grade Hyaluronic Acid Sales Market Share by Country (2020-2031)
Figure 43. Latin America Pharma-Grade Hyaluronic Acid Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Pharma-Grade Hyaluronic Acid Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Pharma-Grade Hyaluronic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Pharma-Grade Hyaluronic Acid by Type (2020-2031)
Figure 53. Global Revenue Market Share of Pharma-Grade Hyaluronic Acid by Type (2020-2031)
Figure 54. Global Pharma-Grade Hyaluronic Acid Price (US$/Kg) by Type (2020-2031)
Figure 55. Global Sales Market Share of Pharma-Grade Hyaluronic Acid by Application (2020-2031)
Figure 56. Global Revenue Market Share of Pharma-Grade Hyaluronic Acid by Application (2020-2031)
Figure 57. Global Pharma-Grade Hyaluronic Acid Price (US$/Kg) by Application (2020-2031)
Figure 58. Pharma-Grade Hyaluronic Acid Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
